According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated ...
Global Benchmark for Efficient Drug Pricing (GLOBE) Model, CMS's most favored nation (MFN) pricing policy for Medicare Part B ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation. According to Garrett Freeman, sales ...
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance. As regulators sharpen their ...
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains. Supply chain ...
Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet ...
Please check back later for more content.
AI should not be framed as influencing prescribing; it can close the information-access gap by delivering brand-approved, ...
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies. As therapies become more targeted and time-sensitive, ...
Explain why commercialization readiness begins much sooner than executives think. Identify early operational ...
Identify early operational decisions—product handling requirements, product configuration, transportation strategies, temperature management requirements, and supply chain design—that affect ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results